Shares of bioMerieux (OTCMKTS:BMXMF – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $130.7675, but opened at $125.34. bioMerieux shares last traded at $125.34, with a volume of 26 shares trading hands.
bioMerieux Stock Down 4.2%
The firm’s 50 day moving average price is $133.84 and its two-hundred day moving average price is $136.75. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08.
About bioMerieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Further Reading
- Five stocks we like better than bioMerieux
- Expert Stock Trading Psychology Tips
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Stocks Flashing Buy Signals With $8.5 Billion in Buybacks
- Investing in Construction Stocks
- Freshpet Insiders Called the Bottom: Now It’s Time to Buy
Receive News & Ratings for bioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.
